Professor Eli Schwartz, founder of the Center for Travel Medicine and Tropical Diseases at Sheba Medical Center in Tel Hashomer, Israel, completed a clinical trial of Ivermectin last week, a drug approved by the US Food and Drug Administration; to be more precise, Ivermectin is a broad-spectrum antiparasitic agent that has proven its effectiveness in the fight against viruses, informs Jerusalem Post.
Ivermectin is often used in 3rd world countries because it’s cheap and effective. According to unpublished data, Schwartz has claimed that the drug helps to “eliminate” the virus in just six days.
Moreover, the chances of being tested negative for coronavirus were three times higher for the group that received ivermectin than for the placebo group, he tells The Jerusalem Post.
“From a public-health point of view, the majority of patients with corona are mild cases, and 90% of these people are isolated outside of the hospital. If you have any kind of drug that can shorten the duration of the infectiousness of these patients, that would be dramatic, as then they will not infect others.” said Schwartz in a recent interview.
Schwartz also said the results show that the drug may be given at the onset of the disease and could thus prevent deteriorating health and hospitalization.
Professor Schwartz is currently preparing the data for publication. On Monday, he will present his findings to the Ministry of Health and will also send a report to the FDA.
However, the National Institutes of Health (NIH) found that for other indications, “ivermectin has been widely used and is generally well tolerated.”
When Israel launched the mass vaccination campaign, many believed there would be no need for drugs, Schwartz said. What’s more important is that Ivermectin is already approved by the FDA, hence there are no safety issues to be proven.
There is one big problem with Ivermectin though: it is cheap, efficient and there are not much money to be made with it by Big Pharma, so don’t get your hopes too high.
